Stress-related hormone norepinephrine induces interleukin-6 expression in GES-1 cells

In the current literature, there is evidence that psychological factors can affect the incidence and progression of some cancers. Interleukin 6 (IL-6) is known to be elevated in individuals experiencing chronic stress and is also involved in oncogenesis and cancer progression. However, the precise mechanism of IL-6 induction by the stress-related hormone norepinephrine (NE) is not clear, and, furthermore, there are no reports about the effect of NE on IL-6 expression in gastric epithelial cells. In this study, we examined the effect of NE on IL-6 expression in immortalized human gastric epithelial cells (GES-1 cells). Using real-time PCR and enzyme-linked immunoassay, we demonstrated that NE can induce IL-6 mRNA and protein expression in GES-1 cells. The induction is through the β-adrenergic receptor-cAMP-protein kinase A pathway and mainly at the transcriptional level. Progressive 5′-deletions and site-directed mutagenesis of the parental construct show that, although activating-protein-1 (AP-1), cAMP-responsive element binding protein (CREB), CCAAT-enhancer binding protein-β (C/EBP-β), and nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) binding sites are all required in the basal transcription of IL-6, only AP-1 and CREB binding sites in the IL-6 promoter are required in NE-induced IL-6 expression. The results suggest that chronic stress may increase IL-6 secretion of human gastric epithelial cells, at least in part, by the stress-associated hormone norepinephrine, and provides basic data on stress and gastric cancer progression.

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion

The mechanisms of statins relieving the no-reflow phenomenon and the effects of single-dose statins on it are not well known. This study sought to investigate the effects of inflammation on the no-reflow phenomenon in a rabbit model of acute myocardial infarction and reperfusion (AMI/R) and to evaluate the effects of single-dose atorvastatin on inflammation and myocardial no-reflow. Twenty-four New Zealand white male rabbits (5-6 months old) were randomized to three groups of eight: a sham-operated group, an AMI/R group, and an atorvastatin-treated group (10 mg/kg). Animals in the latter two groups were subjected to 4 h of coronary occlusion followed by 2 h of reperfusion. Serum levels of interleukin (IL)-6 were measured by enzyme-linked immunosorbent assay. The expression of interferon gamma (IFN-γ) in normal and infarcted (reflow and no-reflow) myocardial tissue was determined by immunohistochemical methods. The area of no-reflow and necrosis was evaluated pathologically. Levels of serum IL-6 were significantly lower in the atorvastatin group than in the AMI/R group (P<0.01). Expression of IFN-γ in infarcted reflow and no-reflow myocardial tissue was also significantly lower in the atorvastatin group than in the AMI/R group. The mean area of no-reflow [47.01% of ligation area (LA)] was significantly smaller in the atorvastatin group than in the AMI/R group (85.67% of LA; P<0.01). The necrosis area was also significantly smaller in the atorvastatin group (85.94% of LA) than in the AMI/R group (96.56% of LA; P<0.01). In a secondary analysis, rabbits in the atorvastatin and AMI/R groups were divided into two groups based on necrosis area (90% of LA): a small group (<90% of LA) and a large group (>90% of LA). There was no significant difference in the area of no-reflow between the small (61.40% of LA) and large groups (69.87% of LA; P>0.05). Single-dose atorvastatin protected against inflammation and myocardial no-reflow and reduced infarct size during AMI/R in rabbits. No-reflow was not dependent on the reduction of infarct size.

In titulos libri 23-27 Corporis juris civilis Romani

Variantti B.

Synopsis theologiae 27

Invokaatio: In nomine Jesu!

Aphorismi miscellanei (1762-05-27)

Invokaatio: D.D.

De unctione omnia docente, I Joh. II: 27

Invokaatio: Q.B.V.J.D.T.O.M.

De lege fidei gloriationem excludente Rom. III. 27

Invokaatio: J.N.J.

Matkustavan muistin jäljillä : Travelling memories : lives in transition -symposium Helsingissä, 27.-28.11.2014

Seminaariraportti

O mesmo, os outros e o "eles" algumas notas sobre os §§ 25-27 de Sein und Zeit

As palavras que se seguem constituem uma tentativa de explorar os diversos sentidos que revestem a figura do «com» [mit], tal como surge configurada ao longo dos §§ 25-27 de Sein und Zeit. Escutaremos atentamente aquilo que Heidegger tem a dizer a respeito da necessária determinação do ser-no-mundo [in-der-Welt-sein] como ser-com [Mitsein] e veremos, depois, em que medida a sua analítica existencial faz (ou não) depender a constituição do ser-si-mesmo [Selbstsein] da figura do outro. Por último, e em jeito de conclusão, tentaremos mostrar como Heidegger articula a interrogação pela ipseidade ou pelo «quem?» [Wer?] do ser-aí quotidiano [alltägliche Dasein], com uma breve reflexão acerca da inautenticidade [Uneigentlichkeit] fáctica em que o mesmo muitas vezes parece soçobrar. Será então, estamos em crer, o momento apropriado para debatermos o significado da controversa noção heideggeriana de «eles» [das Man], aproveitando também o ensejo para lançarmos a questão relativa à responsabilidade (ética?) do Dasein. Metodologicamente, contornaremos (sempre que possível) os tradicionais comentários a respeito das infinitas modalidades alternativas de tradução do jargão filosófico heideggeriano.